Notes And Other Explanatory Information [Abstract]

HEMOGENYX PHARMACEUTICALS PLC - Filing #5969073

Concept 2024-01-01 to
2024-12-31
Notes and other explanatory information [abstract]
Disclosure of accounting judgements and estimates [text block]
3
Disclosure of auditors' remuneration [text block]
7
Disclosure of basis of consolidation [text block]
Disclosure of basis of preparation of financial statements [text block]
Disclosure of commitments [text block]
23
Disclosure of credit risk [text block]
a)
Disclosure of earnings per share [text block]
9
Disclosure of employee benefits [text block]
6
Disclosure of entity's operating segments [text block]
4
Disclosure of events after reporting period [text block]
26
Disclosure of expenses by nature [text block]
5
Disclosure of financial instruments [text block]
22
Disclosure of general information about financial statements [text block]
1
Disclosure of going concern [text block]
oing concern
Disclosure of income tax [text block]
8
Disclosure of intangible assets [text block]
12
Disclosure of leases [text block]
11
Disclosure of liquidity risk [text block]
b)
Disclosure of market risk [text block]
Disclosure of property, plant and equipment [text block]
10
Disclosure of reclassification of financial instruments [text block]
25
Disclosure of related party [text block]
21
Disclosure of reserves within equity [text block]
19
Disclosure of share capital, reserves and other equity interest [text block]
Disclosure of subsidiaries [text block]
13
Disclosure of trade and other payables [text block]
20
Disclosure of trade and other receivables [text block]
15

Talk to a Data Expert

Have a question? We'll get back to you promptly.